Medicine

Peanut allergy medicine gets closer to approval

Photo: Michael Jacobs/Art in All of Us/Corbis via Getty Images

A vast majority of experts on a federal allergy panel said a new treatment to minimize reactions to peanut allergies is safe and effective, which may signal possible FDA approval of the drug in January.

Why it matters: The treatment, made by Aimmune Therapeutics and sold under the brand name Palforzia, could provide relief to parents worried about their kids getting an anaphylactic reaction from peanut exposure. 

Concerns rise about generic drugs from overseas

The FDA inspects less than 1% of drugs before letting them come into the country.
Illustration: Aïda Amer/Axios

The FDA is inspecting fewer overseas drugmakers as it simultaneously increases the number of generic drug approvals, contributing to concerns about the safety of our generic drug supply, Bloomberg Businessweek reports.

Why it matters: 90% of drugs sold in the U.S. are generics, and 80% of the active ingredients are produced abroad. The FDA inspects less than 1% of drugs before letting them come into the country.